MAY 16, 2017 9:00 AM PDT

WEBINAR: Disease Models

Sponsored by: Thermo Fisher Scientific



DATE: May 16, 2017
TIME: 9:00am PT, Noon ET

Thermo Fisher Scientific is proud to present the SyncD3 webinar series.  As a thought-leader in science our first commitment is to you the scientist and partnering to drive the conversation on current practices, standards and the development of innovation. 

Join us for our continuation of the SyncD3 webinar series and virtual event, where we will discuss cutting-edge tools and topics in the field(s) of Drug Discovery & Development such as:

  • HCS/Phenotypic Assays
  • Functional Genomics & Drug Metabolism
  • 3D models/Organoids
  • Diseased models
  • Stem Cells

We will discuss where these areas intersect and impact drug discovery and development and the future of the industry during a live panel discussion with our presenters and you the audience.  Learn from real field scientists and researchers who are working in the ADME/Tox and Drug Discovery fields and bring your questions for the open forum Q&A session after our presentations. 

If you cannot make the live presentation you are always capable of accessing the recorded information, presentations and Q&A any time after the event by registering here.

ADME/Tox Presentation:  3D Cell Culture: Developing Better In Vitro Cell Models For Drug Discovery

Organoids are emerging as advanced 3D cell models that have the potential to revolutionize our understanding of human development and disease. This technology can be utilized to generate ‘micro-tissues’ from human embryonic or adult stem cells and iPSCs, that histologically resemble normal tissues and recapitulate some of the functional capabilities of their in vivo counterparts. These features suggest organoids may also have unique advantages for drug discovery and the potential for personalized toxicology. This talk will give a general overview of organoid technology and other 3D cell models highlighting ongoing R&D activities at Thermo Fisher Scientific.

Drug Discovery Presentation:   Using iPSCs and Genome Engineering to Build Disease Models

Developing therapies for human diseases continues to face obstacles, particularly in translating targets or compounds identified by in vitro screening campaigns to valid targets or efficacious and safe compounds once tested in humans.  Here we discuss strategies that leverage induced pluripotent stem cells (iPSCs) to increase the relevance of cell models for these in vitro approaches.  We review current advances in genome engineering and how to leverage a portfolio of these tools to generate knock-out and knock-in models for use in target or compound identification.  Specifically, we demonstrate this approach with induced pluripotent stem cells (iPSCs) to build isogenic disease models, which can be further differentiated to various cell types of interest that are more directly related to a disease area than commonly used immortalized cell lines.  We expect strategies combining genome engineering and stem cells to provide platforms for more robust disease models that will provide more predictable translation of in vitro to in vivo results.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
NOV 17, 2021 8:00 AM PST
NOV 17, 2021 8:00 AM PST
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
SEP 29, 2021 11:00 AM PDT
SEP 29, 2021 11:00 AM PDT
Date: Septembr 29, 2021 Time: 11:00am (PDT), 2:00pm (EDT) 3D cell models are becoming increasingly popular for studying complex biological effects, tissue functionality, and diseases. While...
MAY 16, 2017 9:00 AM PDT

WEBINAR: Disease Models

Sponsored by: Thermo Fisher Scientific


Cancer Research

Cell Biology

Molecular Biology

Cell Culture





Gene Expression

Clinical Research

Cancer Therapeutics

Drug Discovery





North America60%





South America1%

Registration Source

Website Visitors100%

Job Title




Research Scientist12%


Facility/Department Manager10%

Post Doc7%

Lab Management4%

Clinical Laboratory Scientist4%

Medical Doctor/Specialist4%

Medical Laboratory Technician4%




Academic Institution16%

Research Institute7%

Biotech Company6%

Clinical Laboratory5%

Life Science Company4%

Non-Profit Organization3%

Medical School3%


Pharmaceutical Company2%


Contract Research Organization (Cro)2%


Ambulatory Care1%

Medical Center1%


Show Resources
Loading Comments...
Show Resources